MilWealth Group’s Elanco Animal Health ELAN Stock Holding History

MilWealth Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-34	Closed	-$965	–	106
2021 Q4	$965	Hold	34	–	–	﹤0.01%	153
2021 Q3	$1.08K	Buy	+34	New	+$1.14K	﹤0.01%	158

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MilWealth Group's ELAN Position: Q1 2022 in Review

MilWealth Group sold out of Elanco Animal Health (ELAN) in Q1 2022, closing a stake of 34 shares — an estimated $965 sold.

MilWealth Group first reported a position in ELAN in Q3 2021 and held it in 2 quarters. The position peaked at $1.08K in Q3 2021. 472 funds tracked by Wall St. Rank hold ELAN as of Q1 2022.

MilWealth Group reported no remaining Elanco Animal Health position as of Q1 2022 after selling out during the quarter.
MilWealth Group sold 34 Elanco Animal Health shares in Q1 2022, an estimated $965.
MilWealth Group first reported a position in Elanco Animal Health in Q3 2021 and held it in 2 quarters.
MilWealth Group's Elanco Animal Health position peaked at $1.08K in Q3 2021.
472 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2022.

Based on MilWealth Group's 13F filing for Q1 2022, filed 9 May 2023.